BAKER BROS ADVISORS LLC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is a 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a Director in INCYTE CORP ($INCY) and a Director in ALEXION PHARMACEUTICALS INC ($ALXN) and a 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and a Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and a in XOMA Corp ($XOMA) and a Director in ACADIA PHARMACEUTICALS INC ($ACAD) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in GENOMIC HEALTH INC ($GHDX) and a 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and a 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and a Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and a Director in Kodiak Sciences Inc. ($KOD) and a 10% Owner in Invitae Corp ($NVTA) and a 10% Owner in Atreca, Inc. ($BCEL) and a in Mirati Therapeutics, Inc. ($MYG) and a 10% Owner in Mirati Therapeutics, Inc. ($MYG) and a in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and a in Intellia Therapeutics, Inc. ($NTLA) and a Director in BeiGene, Ltd. ($BGNE) and a Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and a in HOOKIPA Pharma Inc. ($HOOK).

Over the past year BAKER BROS ADVISORS LLC has been an insider in 12 companies. The total value of shares held by BAKER BROS ADVISORS LLC in these companies amounts to $912,080,594.

BAKER BROS ADVISORS LLC Director
ACADIA PHARMACEUTICALS INC
Director
ALEXION PHARMACEUTICALS, INC.
10% Owner
Atreca, Inc.
Director
BeiGene, Ltd.
10% Owner
BELLICUM PHARMACEUTICALS, INC
10% Owner
BIOCRYST PHARMACEUTICALS INC
Director
GENOMIC HEALTH INC
HOOKIPA Pharma Inc.
10% Owner, Director
IDERA PHARMACEUTICALS, INC.
Director
INCYTE CORP
Intellia Therapeutics, Inc.
10% Owner
Invitae Corp
Director
Kiniksa Pharmaceuticals, Ltd.
Director
Kodiak Sciences Inc.
Mirati Therapeutics, Inc.
Director, 10% Owner
Neoleukin Therapeutics, Inc.
RHYTHM PHARMACEUTICALS, INC.
Director
SEATTLE GENETICS INC /WA
XOMA Corp
$ 912080594 The total value of shares held by BAKER BROS ADVISORS LLC
Insider Rank

BAKER BROS ADVISORS LLC ranks 105 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: 667 MADISON AVENUE 21ST FLOOR NEW YORK US 10065 NY

Companies in which BAKER BROS ADVISORS LLC is an Insider

ACADIA PHARMACEUTICALS INC

Trading Symbol: ACAD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 3,315,146 shares
Current Value: $126,605,426
Latest Transaction: Jun 28 2019
$ACAD Market Capitalization: $4.67B
$ACAD Previous Close: $38.19

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 35x
Sell: 4x
Shares Bought: 17,399,321
Shares Sold: 969,131
Share Difference: +16,430,190
Value Difference: -$304,892,284

ALEXION PHARMACEUTICALS, INC.

Trading Symbol: ALXN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 983,179 shares
Current Value: $125,571,622
Latest Transaction: May 30 2019
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 30x
Sell: 18x
Shares Bought: 1,357,363
Shares Sold: 300,000
Share Difference: +1,057,363
Value Difference: -$119,791,804

Atreca, Inc.

Trading Symbol: BCEL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 309,730 shares
Latest Transaction: Jun 26 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 3,532,760
Shares Sold: 0
Share Difference: +3,532,760
Value Difference: $0

BeiGene, Ltd.

Trading Symbol: BGNE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 1,028,034 shares
Current Value: $36,926,981
Latest Transaction: Jun 07 2019
$BGNE Market Capitalization: $1.14B
$BGNE Previous Close: $35.92

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 16x
Sell: 3x
Shares Bought: 9,895,463
Shares Sold: 813,939
Share Difference: +9,081,524
Value Difference: -$896,758,632

BELLICUM PHARMACEUTICALS, INC

Trading Symbol: BLCM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 412,246 shares
Current Value: $5,181,932
Latest Transaction: Jan 19 2018
$BLCM Market Capitalization: $335.83M
$BLCM Previous Close: $12.57

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 9x
Shares Bought: 166,666
Shares Sold: 880,735
Share Difference: -714,069
Value Difference: +$5,219,903

BIOCRYST PHARMACEUTICALS INC

Trading Symbol: BCRX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 1,656,688 shares
Current Value: $9,393,421
Latest Transaction: Aug 16 2016
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 8x
Shares Bought: 0
Shares Sold: 4,046,590
Share Difference: -4,046,590
Value Difference: +$20,251,102

GENOMIC HEALTH INC

Trading Symbol: GHDX
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 173,425 shares
Current Value: $4,767,453
Latest Transaction: Jul 03 2019
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 56x
Sell: 611x
Shares Bought: 142,908
Shares Sold: 4,471,903
Share Difference: -4,328,995
Value Difference: +$329,965,940

HOOKIPA Pharma Inc.

Trading Symbol: HOOK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC:
Holdings: 72,128 shares
Latest Transaction: Apr 23 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 892,857
Shares Sold: 0
Share Difference: +892,857
Value Difference: -$12,499,998

IDERA PHARMACEUTICALS, INC.

Trading Symbol: IDRA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: 10% Owner, Director
Holdings: 350,721 shares
Current Value: $547,125
Latest Transaction: Jul 03 2019
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 30x
Sell: 2x
Shares Bought: 28,562,769
Shares Sold: 238,234
Share Difference: +28,324,535
Value Difference: -$21,972,994

INCYTE CORP

Trading Symbol: INCY
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 2,827,076 shares
Current Value: $334,103,842
Latest Transaction: Jul 02 2019
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 30x
Sell: 2x
Shares Bought: 648,567
Shares Sold: 2,295,944
Share Difference: -1,647,377
Value Difference: -$14,084,602

Intellia Therapeutics, Inc.

Trading Symbol: NTLA
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of BAKER BROS ADVISORS LLC:
Holdings: 976,214 shares
Current Value: $12,983,646
Latest Transaction: May 11 2016
$NTLA Market Capitalization: $471.17M
$NTLA Previous Close: $13.30

Last 4 weeks trend: HOLD
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 1,062,120
Shares Sold: 0
Share Difference: +1,062,120
Value Difference: -$3,600,000

Invitae Corp

Trading Symbol: NVTA
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 845,858 shares
Current Value: $7,443,550
Latest Transaction: Mar 29 2018
$NVTA Market Capitalization: $281.95M
$NVTA Previous Close: $8.80

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 1,844,444
Shares Sold: 0
Share Difference: +1,844,444
Value Difference: -$9,399,998

Kiniksa Pharmaceuticals, Ltd.

Trading Symbol: KNSA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 98,980 shares
Latest Transaction: Jun 07 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 1x
Shares Bought: 3,029,680
Shares Sold: 200,423
Share Difference: +2,829,257
Value Difference: -$54,000,000

Kodiak Sciences Inc.

Trading Symbol: KOD
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 372,792 shares
Latest Transaction: Jun 05 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 8x
Sell: 0x
Shares Bought: 9,145,115
Shares Sold: 0
Share Difference: +9,145,115
Value Difference: -$28,955,936

Mirati Therapeutics, Inc.

Trading Symbol: MYG
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC:
Holdings: 141,244 shares
Latest Transaction: Nov 20 2017

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 7x
Sell: 12x
Shares Bought: 594,019
Shares Sold: 999,358
Share Difference: -405,339
Value Difference: +$5,084,890

Neoleukin Therapeutics, Inc.

Trading Symbol: AQXP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director, 10% Owner
Holdings: 1,170,550 shares
Current Value: $22,018,046
Latest Transaction: Aug 08 2019
$AQXP Market Capitalization: $451.60M
$AQXP Previous Close: $18.81

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 43x
Sell: 0x
Shares Bought: 4,024,859
Shares Sold: 0
Share Difference: +4,024,859
Value Difference: -$45,833,516

RHYTHM PHARMACEUTICALS, INC.

Trading Symbol: RYTM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC:
Holdings: 82,969 shares
Latest Transaction: Oct 06 2017

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 2,049,020
Shares Sold: 0
Share Difference: +2,049,020
Value Difference: -$15,045,000

SEATTLE GENETICS INC /WA

Trading Symbol: SGEN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 4,302,354 shares
Current Value: $261,540,100
Latest Transaction: Jun 07 2019
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 34x
Sell: 1x
Shares Bought: 5,535,988
Shares Sold: 1,002,483
Share Difference: +4,533,505
Value Difference: -$277,314,812

XOMA Corp

Trading Symbol: XOMA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC:
Holdings: 90,538 shares
Current Value: $381,165
Latest Transaction: Jul 23 2015
$XOMA Market Capitalization: $25.10M
$XOMA Previous Close: $4.21

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC

Sentiment: All, ACAD, ALXN, BCEL, BGNE, BLCM, BCRX, GHDX, HOOK, IDRA, INCY, NTLA, NVTA, KNSA, KOD, MYG, AQXP, RYTM, SGEN, XOMA

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 08 2019AQXPAQUINOX PHARMACEUT ...BAKER BROS. ADVISORS LPDirectorBuyP3.1550,436159,02010,105,15910.1 M to 10.1 M (+0.50 %)
Aug 08 2019AQXPAQUINOX PHARMACEUT ...BAKER BROS. ADVISORS LPDirectorBuyP3.154,56414,3901,200,5201.2 M to 1.2 M (+0.38 %)
Aug 08 2019AQXPAQUINOX PHARMACEUT ...BAKER BROS. ADVISORS LPDirectorBuyP3.02209,382633,25510,054,7239.8 M to 10.1 M (+2.13 %)
Aug 08 2019AQXPAQUINOX PHARMACEUT ...BAKER BROS. ADVISORS LPDirectorBuyP3.0218,94357,2911,195,9561.2 M to 1.2 M (+1.61 %)
Aug 08 2019AQXPAQUINOX PHARMACEUT ...BAKER BROS. ADVISORS LPDirectorBuyP2.965,86917,3589,845,3419.8 M to 9.8 M (+0.06 %)
Aug 08 2019AQXPAQUINOX PHARMACEUT ...BAKER BROS. ADVISORS LPDirectorBuyP2.965311,5701,177,0131.2 M to 1.2 M (+0.05 %)
Aug 08 2019AQXPAQUINOX PHARMACEUT ...BAKER BROS. ADVISORS LPDirectorBuyP2.8565,568186,6669,839,4729.8 M to 9.8 M (+0.67 %)

View all BAKER BROS ADVISORS LLC insider transactions.